• Medicine
  • Published 2016

A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck (HNSCC)

@inproceedings{Forster2016API,
  title={A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck (HNSCC)},
  author={Martin Forster and Renata G. Mendes and Kevin J. Harrington and T Guerrero-urbano and Helen Baines and Spanswick and Leah Ensell and John M Hartley and Sola Adeleke and Paul Gougis and Dominic Leader and Andr{\'e} Luiz Lopes and Jonathan Teague and Sharon Forsyth and Sandy Beare},
  year={2016}
}

Topics from this paper.